Clinical Trial Update: Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 trial update on ularitide for acute decompensated heart failure reports efficacy and safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure

Drugs mentioned

• Ularitide (ularitide)

Snippet

Sponsor: Cardiorentis | Conditions: Acute Decompensated Heart Failure | Phase 3 | Status: COMPLETED